Vitamin B3 may help prevent some common skin cancers
the ONA take:
A large study has found that a certain B3 vitamin may reduce the risk of the most common skin cancers. Melanoma was not involved in the study, only the more common basal and squamous cell cancers.
The study, funded by Australia’s National Health and Medical Research Council, included 386 people who had at least two skin cancers in the previous 5 years.
In the double-blind study, the participants took either 500 mg of the B3 vitamin nicotinamide or dummy pills twice a day for 1 year, and were followed for 6 months after they stopped taking the pills. Those taking the vitamin had a 23% lower rate of new cancers.
In addition, the rate of precancers was also reduced, by 11% after 3 months and 20% after 9 months. However, the benefits did not continue once the pills were stopped. Six months after discontinuing the pills, the rate of new skin cancers was similar in both groups.
Nicotinamide is thought to help repair the DNA damage caused by sun exposure. Vitamin use for cancer prevention, however, is controversial, and some studies have even found them to be harmful.
Furthermore, despite the positive results of this study, the researchers stress that vitamin use is not for people who have not yet had one of these cancers and that people should always practice basic sun-sensible behaviors.
A certain B3 vitamin may reduce the risk of the most common skin cancers.
- More Than Half of Melanomas Are Self-Detected, Especially by Women
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Study Identifies Factors Associated With Infection-related Complications in ALL
- Immune Checkpoint-Related Neurotoxicity May Be More Common During Combination Treatment
- New Recommendations for Secondary Prevention of Cervical Cancer
- Nonadherence to Posttreatment Imaging Follow-up Common Among Breast Cancer Survivors
- HIIT Improves Cardiorespiratory Fitness in Patients With Resectable NSCLC
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|